Product: BREXAFEMME (Ibrexafungerp) tablets 150 mg, 4 count cartons, Rx Only, Manufactured for and distributed by SCYNEXIS, Inc., Jersey City, NJ 07302  NDC 75788-115-04
Reason for recall: Cross Contamination with Other Products: Potential cross-contamination of ibrexafungerp citrate drug substance with ezetimibe (a non-antibacterial beta-lactam compound).
Recall initiated: 20230925
Status: Completed
Classification: Class I
Recall type: Voluntary: Firm initiated